A non-surgical, non-pharmaceutical, non-invasive, evidence-based option for foot injury and wound care that provides superior outcomes that providers and patients are looking for.
Successful Providers are staying ahead in a declining reimbursement environment by adopting SoftWave’s non-invasive, regenerative solution.
SoftWave is used at leading national and international research and medical centers as well as professional sport organizations including: MLB, NFL, NBA, NHL, MLS, NCAA, PGA, USGA, USATF, WNBA, Premier League, and UFC.
SoftWave should be a part of your regenerative
medicine and pain management. It’s really effective for your patients. I use it as part of my post operative regime as well as players will use before play, during half time and after for quicker recovery. From plantar fasciitis and tendinitis to stress fractures for bone healing, it works. And, it’s a more comfortable option that patients appreciate.
Having one machine that does so much— without the need for steroids—is incredible. It helps our patients heal faster, improves their quality of life, and boosts our clinic’s productivity. It’s a great investment and has become a powerful referral source.
SoftWave’s patented broad-focused applicator design makes it possible to spread energy to a large area of both superficial and deep tissue soliciting a biological response to the target area to initiate the body’s natural healing process.
With quick treatment times and easy operation, it seamlessly integrates into care plans. As a non-invasive solution, SoftWave requires no injections, drugs, or surgery, making it a comprehensive and versatile option for regenerative medicine.
The procedure typically lasts 10-15 minutes depending on the injured area. During the treatment, the clinician carefully moves the applicator with its flexible elastic membrane over the targeted area. Patient biofeedback enhances accuracy and precision ensuring the therapy is concentrated exactly where it is needed, leading to improved patient outcomes.
SoftWave offers on-site personalized training ensuring everyone is fully equipped and confident in administering SoftWave treatments. With hands-on guidance and support, your team can maximize efficiency and patient outcomes from day one.
Fast and easy to use
Used in an office/wound clinic/outpatient setting
Mobile unit fits seamlessly within wound care clinic
Does not require a sterile environment
Average treatment time is less than 10 minutes
Once-a-week treatment
Faster wound healing than standard of care
Non-invasive
Adjunct therapy can be used alone or in combination with other Advanced Wound Care
Decreases complications and amputation rates
FDA cleared to treat DFUs
Reimbursement Pathway with CPT codes 0512T and 0513T
Less costly than HBOT, NPWT, Skin Substitutes
Extracorporeal Shock Wave Therapy (EWST) has been widely used to treat a wide range of conditions, including complex and chronic non-healing soft tissue wounds with different etiologies, such as DFUs, peripheral arterial diseases, venous leg ulcers, and pressure ulcers.
ESWT has been demonstrated to positively impact the four stages of wound healing:
EWST is an adjunctive therapy that can be combined with standard wound care therapies.
ESWT is an evidence-based, non-invasive, convenient treatment for chronic wounds, including DFUs. One study found that using ESWT to treat chronic wounds resulted in nearly three-fourths (74.03%) of wounds closing and not reappearing in the same location.
Moreover, a meta-analysis that looked at five randomized studies implementing EWST across multiple types of wounds, including burns and DFUs, found a 20% absolute efficacy advantage for ESWT relative to control treatments and achievement of 50% of the performance goals outlined for ESWT effectiveness.
Click on the above image to access our White Paper
